Streetbeat News

Stock Prices

AAPL

ADBE

QCOM

XLV

The CNBC Halftime Report highlighted final trades including QUALCOMM, Apple, Adobe, and the SPDR Select Sector Fund - Health Care. These stocks and ETF were discussed for their potential investment opportunities.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 4:58 pm

CDMO

Avid Bioservices (NASDAQ:CDMO) shares surged 16.6% after reporting better-than-expected Q4 sales for fiscal year 2024. Despite a larger-than-expected loss per share, the company beat sales estimates and issued positive revenue guidance for fiscal year 2025. RBC Capital reiterated an Outperform rating with an $8 price target.

Portfolio Pulse from Dylan Berman

July 03, 2024 | 4:57 pm

TWLO

Twilio shares are trading lower after the company confirmed an unsecured API endpoint allowed threat actors to verify phone numbers of Authy users.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 4:56 pm

ASRT

Assertio Holdings shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 4:53 pm

PR

Permian Resources Corp (NYSE:PR) received an upgrade from BMO Capital Markets due to its top-tier cost structure and strong operational performance. Analyst Phillip Jungwirth upgraded the stock from Market Perform to Outperform, citing the company's large-scale and low-cost footprint in the Delaware Basin, impressive M&A track record, and potential for continued growth.

Portfolio Pulse from Priya Nigam

July 03, 2024 | 4:50 pm

ABBV

Deep-pocketed investors have adopted a bearish approach towards AbbVie (NYSE:ABBV), as revealed by Benzinga's options scanner. The majority of options activities are bearish, with significant trading volumes and open interest in a price band between $135.0 and $180.0. AbbVie's stock is currently neutral with a price of $163.87, and earnings are expected in 22 days. Analysts have mixed ratings with a consensus target price of $191.25.

Portfolio Pulse from Benzinga Insights

July 03, 2024 | 4:46 pm

SOXX

SPY

Hedge funds have been selling US tech stocks at the fastest pace in seven years, particularly semiconductor, software, and internet stocks. This sell-off in June 2024 follows a significant rally in the tech sector, which has driven the SPDR S&P 500 ETF Trust (SPY) to all-time highs. The iShares Semiconductor ETF (SOXX) has also seen substantial gains, despite the recent drawdown.

Portfolio Pulse from Hayden Buckfire

July 03, 2024 | 4:46 pm

AMZN

Jeff Bezos, founder of Amazon, plans to sell $5 billion in Amazon shares, potentially to raise cash for purchasing the Seattle Seahawks. This follows his previous sale of $8.5 billion in shares earlier this year.

Portfolio Pulse from Chris Katje

July 03, 2024 | 4:45 pm

NVO

A new study has found a potential link between Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, and a serious eye condition called nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss. The study showed that individuals with diabetes or obesity who were prescribed semaglutide had a significantly higher risk of developing NAION compared to those using non-GLP-1 drugs. However, the study has limitations and does not establish causality.

Portfolio Pulse from Vandana Singh

July 03, 2024 | 4:41 pm

AMC

CMCSA

CNK

DIS

PARA

The upcoming simultaneous release of 'Wicked' and 'Gladiator II' is drawing comparisons to the successful 'Barbenheimer' weekend. Universal's 'Wicked' will now open on Nov. 22, 2024, competing with Paramount's 'Gladiator II'. This could boost ticket sales and benefit movie theater stocks like AMC and Cinemark.

Portfolio Pulse from Chris Katje

July 03, 2024 | 4:41 pm